Eric C. Ko
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Immunology top 10%
- Immune cells in cancer
- Immunotherapy and Immune Responses
Papers in
-
- Prostate Cancer Diagnosis and Treatment 4
- Lung Cancer Diagnosis and Treatment 3
- Lung Cancer Treatments and Mutations 2
-
- Immunotherapy and Immune Responses 6
- Co-authors
- Silvia Chiara Formenti (6 shared papers)David Raben (1 shared paper)Johnny Kao (6 shared papers)Shu‐Hsia Chen (5 shared papers)Soldano Ferrone (7 shared papers)Samuel G. Eisenstein (3 shared papers)Shibo Fu (3 shared papers)Andrew Gregory Sikora (2 shared papers)
- Journals
- The Journal of Immunology (3 papers)International Journal of Radiation Oncology*Biology*Physics (2 papers)Advances in Radiation Oncology (2 papers)Clinical Cancer Research (2 papers)PLoS ONE (2 papers)
- Partner nations
- United StatesChinaTaiwan
In The Last Decade
Eric C. Ko
39 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 76
- Oncology 369
- Immunology 246
- Otorhinolaryngology 69
- Pulmonary and Respiratory Medicine 259
- Radiation 45
Countries citing papers authored by Eric C. Ko
This map shows the geographic impact of Eric C. Ko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric C. Ko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric C. Ko more than expected).
Fields of papers citing papers by Eric C. Ko
This network shows the impact of papers produced by Eric C. Ko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric C. Ko. The network helps show where Eric C. Ko may publish in the future.
Co-authors
The 25 scholars most cited alongside Eric C. Ko, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 214 | |
| 2 | 2010 | 126 | |
| 3 | 2015 | 97 | |
| 4 | 2018 | 92 | |
| 5 | 2019 | 66 | |
| 6 | 2012 | 65 | |
| 7 | 1999 | 60 | |
| 8 | 2013 | 59 | |
| 9 | 2018 | 54 | |
| 10 | 2000 | 43 | |
| 11 | 2006 | 36 | |
| 12 | 2011 | 31 | |
| 13 | 2003 | 28 | |
| 14 | 2012 | 25 | |
| 15 | 2005 | 24 | |
| 16 | 2004 | 22 | |
| 17 | 2005 | 21 | |
| 18 | 2007 | 18 | |
| 19 | 2011 | 18 | |
| 20 | 2020 | 18 |
About Eric C. Ko
Eric C. Ko is a scholar working on Pulmonary and Respiratory Medicine, Immunology, Radiation, Radiology, Nuclear Medicine and Imaging and Oncology, having authored 41 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (6 papers), Immunotherapy and Immune Responses (6 papers), Advanced Radiotherapy Techniques (5 papers), Breast Cancer Treatment Studies (4 papers), Effects of Radiation Exposure (4 papers), Prostate Cancer Diagnosis and Treatment (4 papers), Lung Cancer Diagnosis and Treatment (3 papers) and Lung Cancer Treatments and Mutations (2 papers). The work is most often cited by research in Oncology (369 citations), Immunology (246 citations), Otorhinolaryngology (69 citations), Pulmonary and Respiratory Medicine (259 citations) and Radiation (45 citations). Eric C. Ko has collaborated with scholars based in United States, China and Taiwan. Frequent co-authors include Silvia Chiara Formenti, David Raben, Johnny Kao, Shu‐Hsia Chen, Soldano Ferrone, Samuel G. Eisenstein, Shibo Fu, Andrew Gregory Sikora, Xinhui Wang and Richard G. Stock. Their work appears in journals such as The Journal of Immunology, International Journal of Radiation Oncology*Biology*Physics, Advances in Radiation Oncology, Clinical Cancer Research and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.